Matches in UGent Biblio for { <https://biblio.ugent.be/publication/1842961#aggregation> ?p ?o. }
Showing items 1 to 50 of
50
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B338151.
- aggregation creator B338152.
- aggregation creator B338153.
- aggregation creator B338154.
- aggregation creator B338155.
- aggregation creator B338156.
- aggregation creator B338157.
- aggregation creator B338158.
- aggregation creator B338159.
- aggregation creator B338160.
- aggregation creator B338161.
- aggregation creator B338162.
- aggregation creator B338163.
- aggregation creator B338164.
- aggregation creator B338165.
- aggregation creator B338166.
- aggregation creator B338167.
- aggregation creator B338168.
- aggregation creator person.
- aggregation date "2011".
- aggregation format "application/pdf".
- aggregation hasFormat 1842961.bibtex.
- aggregation hasFormat 1842961.csv.
- aggregation hasFormat 1842961.dc.
- aggregation hasFormat 1842961.didl.
- aggregation hasFormat 1842961.doc.
- aggregation hasFormat 1842961.json.
- aggregation hasFormat 1842961.mets.
- aggregation hasFormat 1842961.mods.
- aggregation hasFormat 1842961.rdf.
- aggregation hasFormat 1842961.ris.
- aggregation hasFormat 1842961.txt.
- aggregation hasFormat 1842961.xls.
- aggregation hasFormat 1842961.yaml.
- aggregation isPartOf urn:issn:0003-4967.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel".
- aggregation abstract "Introduction Given the safety issues of nonsteroidal anti-inflammatory drugs (NSAID) and the robustness of guidelines, making treatment choices in daily clinical practice is increasingly difficult. This study aimed systematically to analyse the opinions of a multidisciplinary European expert panel on the appropriateness of different NSAID, with or without the use of a proton pump inhibitor (PPI), in individual patients with chronic rheumatic disease. Methods Using the Research and Development/University of California at Los Angeles appropriateness method, the appropriateness of five (non-)selective NSAID with or without a PPI was assessed for 144 hypothetical patient profiles, ie, unique combinations of cardiovascular and gastrointestinal risk factors. Appropriateness statements were calculated for all indications. Results All options without PPI were considered appropriate in patients with no gastrointestinal/cardiovascular risk factors. Cyclooxygenase-2 selective inhibitors (C2SI) alone and non-selective NSAID plus PPI were preferred for patients with elevated gastrointestinal risk and low cardiovascular risk. Naproxen plus PPI was favoured in patients with high cardiovascular risk. For the combination of high gastrointestinal/high cardiovascular risk the use of any NSAID was discouraged; if needed, naproxen plus PPI or a C2SI plus PPI could be considered. Discussion The panel results may support treatment considerations at the level of individual patients, according to their gastrointestinal/cardiovascular risk profile.".
- aggregation authorList BK635209.
- aggregation endPage "822".
- aggregation issue "5".
- aggregation startPage "818".
- aggregation volume "70".
- aggregation aggregates 1843029.
- aggregation isDescribedBy 1842961.
- aggregation similarTo ard.2010.128660.
- aggregation similarTo LU-1842961.